PathMaker Neurosystems Launches European Clinical Trial Of MyoRegulator

PathMaker Neurosystems has announced that it has initiated and successfully enrolled the first patient in its European clinical trial to evaluate MyoRegulator for the non-invasive treatment of spasticity secondary to stroke. The clinical trial is being conducted by France’s prestigious Brain and Spine Institute (Institut du Cerveau et de la Moelle Epinière – ICM) at the Pitié-Salpêtrière Hospital in Paris, France, […]